Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.909 USD | +2.13% | -1.56% | -33.33% |
Apr. 18 | Top Premarket Decliners | MT |
Apr. 17 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Financials (USD)
Sales 2022 | 822K | Sales 2023 | 3.02M | Capitalization | 3.34M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -8M | EV / Sales 2022 | 9.4 x |
Net Debt 2022 | 2.57M | Net Debt 2023 | 8.45M | EV / Sales 2023 | 3.9 x |
P/E ratio 2022 |
-0.47
x | P/E ratio 2023 |
-0.26
x | Employees | 28 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.35% |
Latest transcript on INVO Bioscience, Inc.
1 day | +2.13% | ||
1 week | -1.56% | ||
Current month | -10.00% | ||
1 month | -15.09% | ||
3 months | -17.45% | ||
6 months | -50.82% | ||
Current year | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Shum
CEO | Chief Executive Officer | 55 | 17-10-10 |
Andrea Goren
DFI | Director of Finance/CFO | 56 | 21-06-13 |
J. Chris Jensen
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trent Davis
BRD | Director/Board Member | 56 | 19-12-15 |
Barbara Ryan
BRD | Director/Board Member | 64 | 20-09-13 |
Corporate Secretary | 55 | 08-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.9 | +1.12% | 17 620 |
24-05-24 | 0.89 | +2.29% | 40,574 |
24-05-23 | 0.8701 | -4.79% | 111,930 |
24-05-22 | 0.9139 | -0.04% | 127,945 |
24-05-21 | 0.9143 | -1.58% | 89,645 |
Delayed Quote Nasdaq, May 28, 2024 at 01:51 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-33.33% | 3.39M | |
-7.65% | 181B | |
-0.21% | 108B | |
-7.02% | 66.12B | |
+2.64% | 50.65B | |
+5.03% | 43.11B | |
+3.49% | 40.74B | |
+19.36% | 31.6B | |
+16.38% | 25.56B | |
-7.09% | 24.16B |
- Stock Market
- Equities
- INVO Stock